Erratum: 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)(J Hypertens (2023) 41 (1874-2071) DOI:10.1097/HJH.0000000000003480)
In ESH 2023 Guidelines, the color in columns 3, 4 and 5 of the row for Class of Recommendation I in Figure 2 has been corrected from white to dark blue in the online version of the paper to match the color used in all other Tables referring to the Level of Evidence. [.]
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2024 |
Verlag/Hrsg.: |
Wolters Kluwer Health
Inc. |
Schlagwörter: | antihypertensive device interventions / antihypertensive drug therapy / blood pressure / cardiac disease / cardiovascular disease / drug combinations / guidelines / heart failure / hypertension / kidney disease / lifestyle interventions / organ damage / patient's follow-up / secondary hypertension / stroke / Europe / France / human / Italy / Netherlands / Spain / Humans |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29197702 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/290137 |